Quick takeaway
Clinical trial evidence in India older adults with mild cognitive impairment focused on integrative intervention and tracked cognition and biomarkers. Targets progression prevention and includes biomarker-aware trial thinking, though details still need careful review.
Why this matters
Targets progression prevention and includes biomarker-aware trial thinking, though details still need careful review.
Key caution
The trial adds stronger causal evidence, but sample size, setting, and follow-up still matter before generalizing widely.